Výsledky vyhledávání - "Max Van Noesel"

Akademický článek

Autor: Thomas Blom, Roosmarijn Lurvink, Leonie Aleven, Maarten Mensink, Tom Wolfs, Miranda Dierselhuis, Natasha van Eijkelenburg, Kathelijne Kraal, Max van Noesel, Martine van Grotel, Godelieve Tytgat

Publikováno v: Frontiers in Oncology, Vol 10 (2021)

The introduction of immunotherapy using an anti-GD2 antibody (dinutuximab, ch14.18) has significantly improved survival rates for high-risk neuroblastoma patients. However, this improvement in survival is accompanied by a substantial immunotherapy-re

Externí odkaz: https://doaj.org/article/9b981075dae247d39e11d9760ced0861

Zobrazit plný text záznamu

Do we need more clinical trials?

Autor: Max Van Noesel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9553d7e46abdc60b60ca0750e4dc8c7e
https://doi.org/10.22541/au.166996802.29215749/v1

Zobrazit plný text záznamu

Clinical trials in desmoid‐type fibromatosis in children and adults: A systematic review

Autor: Max Van Noesel, Olga Husson, Simone Van Maren, Winette Van der Graaf

Publikováno v: Pediatric Blood & Cancer. 69

Desmoid-type fibromatosis (DTF) is a rare locally aggressive soft tissue neoplasm, which occurs in children and adults, with a peak incidence in young adults. For the majority of the patients, DTF is a chronic and symptomatic disease, which affects h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a7203f3574178a30c73c7586770a39
https://doi.org/10.1002/pbc.29831

Zobrazit plný text záznamu

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of

Autor: Fredrik, Sundquist, Kleopatra, Georgantzi, Kirsten Brunsvig, Jarvis, Jesper, Brok, Minna, Koskenvuo, Jelena, Rascon, Max, van Noesel, Per, Grybäck, Joachim, Nilsson, Arthur, Braat, Mikael, Sundin, Sandra, Wessman, Nikolas, Herold, Lars, Hjorth, Per, Kogner, Dan, Granberg, Mark, Gaze, Jakob, Stenman

Publikováno v: Frontiers in pediatrics. 10

Half the children with high-risk neuroblastoma die with widespread metastases. Molecular radiotherapy is an attractive systemic treatment for this relatively radiosensitive tumor.The LuDO-N trial is a phase II, open label, multi-center, single arm, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a85b0b18e29b62edb14bf9aff93def54
https://pubmed.ncbi.nlm.nih.gov/35359899

Zobrazit plný text záznamu

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Autor: Jean, Donadieu, Frederic, Bernard, Max, van Noesel, Mohamed, Barkaoui, Odile, Bardet, Rosella, Mura, Maurizio, Arico, Christophe, Piguet, Virginie, Gandemer, Corinne, Armari Alla, Niels, Clausen, Eric, Jeziorski, Anne, Lambilliote, Sheila, Weitzman, Jan Inge, Henter, Cor, Van Den Bos, Jim, Whitlock

Publikováno v: Blood
Blood, American Society of Hematology, 2015, 126 (12), pp.1415--1423. ⟨10.1182/blood-2015-03-635151⟩
Blood, 126(12), 1415-1423. American Society of Hematology
Blood, 2015, 126 (12), pp.1415--1423. ⟨10.1182/blood-2015-03-635151⟩
Donadieu, J, Bernard, F, van Noesel, M, Barkaoui, M, Bardet, O, Mura, R, Arico, M, Piguet, C, Gandemer, V, Armari Alla, C, Clausen, N, Jeziorski, E, Lambilliote, A, Weitzman, S, Henter, J I, Van Den Bos, C & Salvage Group of the Histiocyte Society 2015, ' Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis : results of an international phase 2 study ', Blood, vol. 126, no. 12, pp. 1415-23 . https://doi.org/10.1182/blood-2015-03-635151

International audience; An international phase 2 study combining cladribine and cytarabine (Ara-C) was initiated for patients with refractory, risk-organ–positive Langerhans cell histiocytosis (LCH) in 2005. The protocol, comprising at least two 5-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b56cf505e17483534796cc0cdbfafd
https://doi.org/10.1182/blood-2015-03-635151

Zobrazit plný text záznamu

Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review

Autor: Kathelijne, Kraal, Thomas, Blom, Max, van Noesel, Leontien, Kremer, Huib, Caron, Godelieve, Tytgat, Heleen, van der Pal

Publikováno v: Pediatric bloodcancer. 64(8)

We performed a systematic review to define the long-term health problems and optimal treatment strategy for patients with neuroblastoma with intraspinal extension. Of 685 identified studies, 28 were included in this review. The burden of long-term he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::34900e7a42a229aa8fd89b849e52e190
https://pubmed.ncbi.nlm.nih.gov/28150396

Zobrazit plný text záznamu

Neuroblastoma With Intraspinal Extension: Health Problems in Long-Term Survivors

Autor: Kathelijne, Kraal, Thomas, Blom, Lieve, Tytgat, Hanneke, van Santen, Max, van Noesel, Anne, Smets, Jos, Bramer, Huib, Caron, Leontien, Kremer, Heleen, van der Pal

Publikováno v: Pediatric bloodcancer. 63(6)

To evaluate the prevalence of health problems in 5-year survivors treated for neuroblastoma (NBL) with intraspinal extension.Retrospective, single center cohort study (using data from Childhood Cancer Registry and medical records) of patients treated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a2dc7915a14c150fae37452fbe74856e
https://pubmed.ncbi.nlm.nih.gov/26890966

Zobrazit plný text záznamu

Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan

Autor: Kathelijne C J M, Kraal, Godelieve A M, Tytgat, Berthe L F, van Eck-Smit, Boen, Kam, Huib N, Caron, Max, van Noesel

Publikováno v: Pediatric bloodcancer. 62(11)

(131)I-metaiodobenzylguanidine ((131) I-MIBG) has a significant anti-tumor effect against neuroblastoma (NBL). Topotecan (TPT) can act as a radio-sensitizer and can up-regulate (131) I-MIBG uptake in vitro in NBL.Determine the efficacy of the combina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bdc28b90e266b0ba61ef9096d06c31b0
https://pubmed.ncbi.nlm.nih.gov/25981988

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání